For research use only
| Cat No. | ABC-TC4305 |
| Product Type | Blood Products |
| Cell Type | Leukopak |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Disease | Osteoarthritis |
| Storage | 4℃ |
Human Osteoarthritis Leukopak provides primary immune cell-rich samples, supporting arthritis pathogenesis, biomarker discovery, and therapy research.
Human Osteoarthritis Leukopak is collected via leukapheresis from donors diagnosed with osteoarthritis (OA), a degenerative joint disease characterized by inflammation and cartilage breakdown. After isolation, the cells are cryopreserved. OA leukopaks provide an immune cell source enriched in monocytes, T cells, and inflammatory mediators relevant to joint inflammation and systemic immune alterations in OA patients. These samples are widely used in research examining cytokine profiles (e.g., IL-1β, TNF-α), macrophage polarization, and biomarker development for OA progression and therapeutic intervention. Repeated freezing and thawing should be avoided. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | Human Osteoarthritis Leukopak, hOA-Leukopak, Leukopak from Osteoarthritis Patients |
| Species | Human |
| Cat.No | ABC-TC4305 |
| Product Category | Primary Cells |
| Size/Quantity | 1 pack |
| Cell Type | Leukopak |
| Growth Mode | Suspension |
| Shipping Info | Ice pack |
| Growth Conditions | 37 ℃, 5% CO2 |
| Disease | Osteoarthritis |
| Storage | 4℃ |
| Product Type | Blood Products |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human Osteoarthritis Leukopak provides a rich source of peripheral blood mononuclear cells (PBMCs) from osteoarthritis (OA) patients. It enables in-depth study of systemic immune activation, macrophage polarization, and T cell dysregulation associated with joint inflammation and cartilage degeneration. This model is widely used in identifying OA-related cytokine profiles, exploring immune targets, and evaluating novel disease-modifying osteoarthritis drugs (DMOADs).
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).